AKTS icon

Aktis Oncology (AKTS)

NASDAQ

(

NaN%

)

1D
5D
1M
6M
1Y
5Y
Market open

AKTS: / ₿ NaN BTC / NaN Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$16.80 - $29.16
$1.11B
-2.4
55.17M
-
No

What is Aktis Oncology (AKTS)?

Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. It has one operating segment focused on the research and development of targeted radiopharmaceuticals.

The Aktis Oncology (AKTS) stock price has been falling

The Aktis Oncology, Inc. Common stock (AKTS) stock price today is , reflecting a NaN% move since the market opened. The company’s market capitalization stands at $1.11B, with a daily trading volume of shares. The previous closing price was .

Get started with Aktis Oncology (AKTS)

Ready to get started? Follow the steps below, or read our guide on how to buy Aktis Oncology stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy AKTS

Search for AKTS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy AKTS.

AKTS FAQs

AKTS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

AKTS is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Aktis Oncology, Inc. Common stock (AKTS) has traded between a low of $16.80 and a high of $29.16.

AKTS is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Aktis Oncology? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
AKTS icon
AKTS

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Aktis Oncology in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

OTRKQ icon

OTRKQ

PPBT icon
ZCMD icon

ZCMD

SVUHF icon

Top losers

Compare the worst-performing stocks of 
the day

CGBSF icon
YOTAR icon

YOTAR

OUSTZ icon

OUSTZ

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.